Revenue
2020
2021
2022
2023
2024
2025
NeuroPace Inc (NPCE)
Price—Loading quote
Net income
2020
2021
2022
2023
2024
2025
Free cash flow
2020
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Revenue | $100.0M | $79.9M | $65.4M | $45.5M | $45.2M | $41.1M |
| Gross profit | $77.2M | $59.1M | $48.1M | $32.5M | $33.4M | $30.3M |
| Research & development | $27.9M | $23.7M | $20.8M | $21.9M | $18.2M | $15.7M |
| Operating expenses | $93.6M | $80.8M | $75.3M | $73.3M | $57.2M | $43.3M |
| Operating income | −$16.3M | −$21.7M | −$27.2M | −$40.8M | −$23.7M | −$13.1M |
| Net income | −$21.5M | −$27.1M | −$33.0M | −$47.1M | −$36.1M | −$24.3M |
| Basic EPSper diluted share | -$0.66 | -$0.93 | -$1.27 | -$1.91 | -$2.17 | -$117.85 |
| Diluted EPSper diluted share | -$0.66 | -$0.93 | -$1.27 | -$1.91 | -$2.17 | -$117.85 |
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Dec 15, 2025Form 4 | Morrell MarthaCHIEF MEDICAL OFFICER | SellCommon Stock | 25.0K | $15.97 | $399.3K | 50.0K |
| May 14, 2025Form 4 | ORBIMED ADVISORS LLC +1TenPercentOwner | SellCommon Stock · indirect | 34.0K | $15.94 | $542.0K | 3.24M |
| May 14, 2025Form 4 | ORBIMED ADVISORS LLC +1TenPercentOwner | SellCommon Stock · indirect | 134.1K | $15.83 | $2.12M | 3.27M |
| Feb 21, 2025Form 4 | Morrell MarthaCHIEF MEDICAL OFFICER | SellCommon Stock | 78.3K | $13.72 | $1.07M | 82.0K |
| Feb 20, 2025Form 4 | KCK LTD.TenPercentOwner | SellCommon Stock | 5.27M | $9.40 | $49.55M | 0 |